Home
Home
About
Contact
Begin your search of the AGOSR Open Access Database
Search
Reset
All Fields
Contributors
DOI
OAI
Results: 1
View Article
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.
Peter Kreuzaler
,
Matthew A Clarke
,
Elizabeth J Brown
,
Catherine H Wilson
,
Roderik M Kortlever
,
Nir Piterman
,
Trevor Littlewood
,
Gerard I Evan
,
Jasmin Fisher
Oct 14, 2019
Cells with higher levels of Myc proliferate more rapidly and supercompetitively eliminate neighboring cells. Nonetheless, tumor cells in aggressive breast cancers typically exhibit significant and stable heterogeneity in their...
Myc
Breast Cancer
cancer heterogeneity
computational modeling
oncogenic signaling
Animals
Drug Resistance
Neoplasm
Female
Genetic Heterogeneity
Mammary Neoplasms
Experimental
Mice
Models
Theoretical
Proto-Oncogene Proteins c-myc
Tumor Suppressor Protein p53
Wnt Signaling Pathway
ras Proteins
Published by: